(1)Impact of the CYP3A4*1G polymorphism and its combination with CYP3A5 genotypes on tacrolimuspharmacokinetics in renal transplant patients./ D7 v2 J) L7 G! e% k" `
(2)The effect of CYP3A4*1G allele on the pharmacokinetics of atorvastatin in Chinese Han patients with coronary heart disease.9 ?3 [1 I+ q: Z7 M/ w
(3)CYP3A4*1G genetic polymorphism influences CYP3A activity and response to fentanyl in Chinese gynecologic patients